| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |